{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:56:05Z","timestamp":1791251765308,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2017,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Addiction to illicit substances or medicines is influenced by cultural, religious, ethnic factors as well as local availability. The purpose of this study was to evaluate the profile of drug users and characteristics of the psychoactive substances used in French overseas territories, using data from the <jats:styled-content style=\"fixed-case\">OPPIDUM<\/jats:styled-content> survey. <jats:styled-content style=\"fixed-case\">OPPIDUM<\/jats:styled-content> is an annual, nationwide, multicentric, cross\u2010sectional study based on specialized care centres that included subjects presenting a drug addiction or under opiate maintenance treatment. The current study includes data from the 2012 and 2013 surveys and focuses on patients included by drug addiction centres located in French overseas departments and territories: French Pacific Ocean (French Polynesia, New Caledonia), French Americas (Guadeloupe, Saint Martin, French Guiana) and Reunion Island. Data from metropolitan France (2013 survey) were included as reference. Two hundred and forty\u2010five patients were included. The sex ratio was 3.7 for the Pacific Ocean, 3.5 for the French Americas and 3.3 for Reunion Island. Cannabis was consumed in all the territories, from 50.8% in Reunion Island to 81.7% in Pacific Ocean. Cocaine was most frequently consumed in the French Americas (61%), mainly in the \u2018freebase\u2019 form (91%), whereas 6.5% of cocaine users in metropolitan France did so. Problematic use of medicines was most frequent in Reunion Island. Heroin seems rarely used in all overseas territories. This study highlights the complexity of substances used in French overseas territories, which often differ from that in mainland France. The relative difference between different areas provides valuable information for future investigations and possible interventions.<\/jats:p>","DOI":"10.1111\/fcp.12233","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T06:57:01Z","timestamp":1472713021000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM survey"],"prefix":"10.1111","volume":"31","author":[{"given":"Am\u00e9lie","family":"Daveluy","sequence":"first","affiliation":[{"name":"CHU Bordeaux Service de Pharmacologie m\u00e9dicale Centre d'Addictovigilance INSERM U1219 F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Frauger","sequence":"additional","affiliation":[{"name":"CNRS INT, Institut de Neurosciences Timone APHM Service de Pharmacologie Clinique Centre d'Addictovigilance Paca Corse Aix Marseille Universit\u00e9 F\u201013005 Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Peyri\u00e8re","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pharmacologie m\u00e9dicale et Toxicologie Centre d'Addictovigilance CHRU Montpellier F\u201034295 Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Moracchini","sequence":"additional","affiliation":[{"name":"CNRS INT, Institut de Neurosciences Timone APHM Service de Pharmacologie Clinique Centre d'Addictovigilance Paca Corse Aix Marseille Universit\u00e9 F\u201013005 Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Haramburu","sequence":"additional","affiliation":[{"name":"CHU Bordeaux Service de Pharmacologie m\u00e9dicale Centre d'Addictovigilance INSERM U1219 F\u201033000 Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Micallef","sequence":"additional","affiliation":[{"name":"CNRS INT, Institut de Neurosciences Timone APHM Service de Pharmacologie Clinique Centre d'Addictovigilance Paca Corse Aix Marseille Universit\u00e9 F\u201013005 Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7103.297"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000337028"},{"key":"e_1_2_8_4_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction.2012 Annual report on the state of the drugs problem in Europe.2012. Available from:http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_190854_EN_TDAC12001ENC_.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_5_1","first-page":"89","article-title":"Doctor shopping reveals geographical variations in opioid abuse","volume":"16","author":"Nordmann S.","year":"2013","journal-title":"Pain Physician"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015009"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015006"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2008014"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2015012"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2014221"},{"key":"e_1_2_8_11_1","unstructured":"Cadet\u2010TairouA..ENa\u2010CAARUD 2010 data: profiles and practices of users.2012. Available from:http:\/\/www.ofdt.fr\/BDD\/publications\/docs\/eisxacs9.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2012.07.013"},{"key":"e_1_2_8_13_1","unstructured":"BeckF. BrugirouxM.\u2010F. CerfN..Les conduites addictives des adolescents polyn\u00e9siens. Enqu\u00eate Ecaap 2009.2010. Available from:http:\/\/www.inpes.sante.fr\/CFESBases\/catalogue\/pdf\/1341.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12024"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000050711"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.14.137828"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"19923","DOI":"10.2807\/ese.16.29.19923-en","article-title":"Epidemiology, surveillance and control of infectious diseases in the European overseas countries and territories, 2011","volume":"16","author":"Jones J.","year":"2011","journal-title":"Euro. Surveill."},{"key":"e_1_2_8_18_1","unstructured":"European Monitoring Centre for Drugs and Drug Addiction.France country overview. Available from:http:\/\/www.emcdda.europa.eu\/countries\/france(last accessed 5 July 2016)."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139168540"},{"key":"e_1_2_8_20_1","unstructured":"INCB.The 2012 Annual Report of the International Narcotics Control Board.2013. Available from:https:\/\/http:\/\/www.incb.org\/incb\/fr\/publications\/annual-reports\/annual-report-2012.html(last accessed 5 July 2016)."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2014.05.090"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2011.03.010"},{"key":"e_1_2_8_23_1","first-page":"28","article-title":"Youth risk behavior surveillance\u2013Pacific Island United States Territories, 2007","volume":"57","author":"Lippe J.","year":"2008","journal-title":"MMWR Surveill. Summ."},{"key":"e_1_2_8_24_1","volume-title":"Flore de la Polyn\u00e9sie fran\u00e7aise","author":"Florence J.","year":"1997"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1515\/9783110812060"},{"key":"e_1_2_8_26_1","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9.Evaluation du potentiel d'abus et de dependance de l'Artane\u00ae(trih\u00e9xyph\u00e9nidyle) et des antiparkinsoniens anticholinergiques. Commission nationale des stup\u00e9fiants et psychotropes F\u00e9vrier 2012.2012. Available from:http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/329a70741f497b7a6ea5a8062c8292b9.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03290220046012"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2003088"},{"key":"e_1_2_8_29_1","first-page":"129","article-title":"L'usage d\u00e9tourn\u00e9 de trihexyph\u00e9nidyle","volume":"30","author":"M\u00e9t\u00e9 D.","year":"2008","journal-title":"Alcool. Addictol."},{"key":"e_1_2_8_30_1","unstructured":"Observatoire R\u00e9gional de Sant\u00e9.Les addictions \u00e0 La R\u00e9union.2012. Available from:http:\/\/www.ors-reunion.org\/IMG\/file\/tableaux_bord\/TB_addictions_2012.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_31_1","unstructured":"Inserm.M\u00e9dicaments psychotropes: consommations et pharmacod\u00e9pendances.2012. Available from:http:\/\/www.inserm.fr\/content\/download\/69083\/523342\/file\/Medicaments-psychotropes_texte.pdf(last accessed 5 July 2016)."},{"key":"e_1_2_8_32_1","unstructured":"R\u00e9seau des centres d'addictovigilance.OSIAP. Available from:http:\/\/www.addictovigilance.fr\/programmes(last accessed 5 July 2016)."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356812"},{"key":"e_1_2_8_34_1","first-page":"17","article-title":"The validity of self\u2010reported drug use in survey research: an overview and critique of research methods","volume":"167","author":"Harrison L.","year":"1997","journal-title":"NIDA Res. Monogr."},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.2515\/therapie\/2012064"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12233","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T11:52:29Z","timestamp":1696247549000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1111\/fcp.12233"],"URL":"https:\/\/doi.org\/10.1111\/fcp.12233","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,5]]},"assertion":[{"value":"2016-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-10-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}